lecture 54.57 Flashcards
ott - pharmacotherapy of schizophrenia and psychotic disorders
what are the key features to define psychotic disorders?
delusions
hallucinations
disorganized thinking and speech
disorganized or abnormal motor behavior
negative symptoms
what is the difference between delusions and hallucinations?
delusion - fixed false beliefs that are not amenable to change event with conflicting evidence
hallucinations - perception like experience that occur without an external stimulus
when does SZ normally appear?
in general –> onset late adolescence to early adulthood
men –> late teens, early 20s
women –> late 20s, early 30s
how is smoking linked to SZ?
associated with induction of 1A2 (not due to nicotine)
hydrocarbons that are produced and inhaled decrease the serum concentration of 1A2 substrate antipsychotics (olanzapine, asenapine, clozapine, and loxapine)
what substances can effect SZ?
marijuana, cocaine, and amphetamine
hasten the onset, exacerbate symptoms, and reduce time to relapse
for pts with SUD and SZ, what should be done?
pt should have mental health treatment at the same time as SZ treatment
what needs to be considered when choosing an antipsychotics?
doses per day
SE
previous drug therapy (success/failure, family hx)
cost of drug therapy (consider PO or IM)
concomitant drug therapy
need for monitoring (labs, weight, ECG)
what dosage form should be considered for antipsychotics?
PO is first-line unless pt presents with reasons to consider IM depot drug therapy first
what are the characteristics of typical antipsychotics?
older agents
primarily D2 receptor antagonists
efficacy for positive symptoms similar to atypical (likely to worsen negative/cognitive symptoms)
more EPS with higher potency typical
what drug is the most commonly used typical antipsychotics?
haloperidol
both PRN and routine
what are the characteristics of partial agonist?
stabilize dopamine transmission
associated with more akathisia than other antipsychotics
approved for adj treatment in depression (BW of suicidal thoughts/behaviors)
what drugs are partial agonists?
aripiprazole (abilify)
brexpiprazole (rexulti)
cariprazine (vraylar)
what are the CP of partial agonists?
substrate 3A4 (all), 2D6 (Abilify/Rexulti only)
moderate akathisia
low (abilify), low-moderate (rexulti/vraylar) weight gain
what are the CP of asenapine (saphris)?
sublingual and patch formulations
1A2 substrate
Qtc prolongation
what are the CP of clozapine (clozaril)?
1A2 substrate
QTc prolongation
SE – sedation, weight gain, Constipation, hypersalivation, dry mouth, GI hypomotility with obstruction risk
what are the BW of clozapine (Clozaril)?
neutropenia
orthostasis
bradycardia
syncope
seizures
myocarditis
cardiomyopathy
what are the CP of olanzapine (zyprexa)?
1A2 substrate
significant weight gain and sedation
high risk metabolic syndrome
DRESS warning
what are the CP of quetiapine (seroquel)?
3A4 substrate
Qtc prolongation
weight gain and sedation
BW – suicidal ideation
what are the specific CP of the transdermal patch formulation of asenapine?
1q24h, rotate patch to minimize application site rxn
warnings for Qtc prolongation
UGT and 1a2 substrate (reduce dose of patch if given with strong 1A2 inhibitors like fluvoxamine)
when should clozapine REMS be monitored?
weekly for 6 months, then biweekly for 6 months, then every 4 weeks
what is the purpose of samidorphan in the combination product lybalvi with olanzapine?
added to mitigate weight gain and metabolic syndrome potential of olanzapine
opioid antagonist with preferential activity at the mu opioid receptor
what are the CP of iloperidone (fanapt)?
high risk for orthostasis and syncope
QTc prolongation
2D6 substrate
what are the CP of lurasidone (latuda)?
3A4 substrate
higher risk for akathisia
warning for suicidal thoughts (adj for bipolar depression)
take with food (350 calories) to icnrease bioavailability
what are the CP of ziprasidone (geodon)?
QTc prolongation (contraindication)
DRESS warning
take WF to increase absorption and bioavailability
3A4 substrate (1/3) and aldehyde oxidase (2/3) – less worry for P450 interactions